Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYRE | ALKS | TGTX | ||
| Company | Spyre Therapeutics Inc | Alkermes Plc | Tg Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 70.08 | 37.06 | 39.02 | ||
| High | 70.08 | 37.28 | 39.32 | ||
| Low | 64.80 | 36.31 | 38.20 | ||
| Latest | 65.29 | 36.83 | 39.50 | ||
| Change | -4.79 | -0.36 | +0.02 | ||
| % Change | -6.84% | -0.97% | +0.05% | ||
| Volume | 365,172 | 310,899 | 247,598 | ||
| 20-Day Average Volume | 1,077,478 | 1,999,220 | 2,260,917 | ||
| Previous Close | 70.08 | 37.19 | 39.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 72.21 | 35.41 | 38.49 | ||
| 20-Day Raw Stochastic | 9.88% | 57.84% | 50.04% | ||
| 20-Day Relative Strength | 51.81 | 58.38 | 56.76 | ||
| Weighted Alpha | +274.20 | +32.11 | +18.11 | ||
| Today's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.59% since 05/12/26 | -4.09% since 05/12/26 | -8.45% since 05/12/26 | ||
| Low | 64.98 on 05/19/26 | 36.31 on 05/19/26 | 38.28 on 05/19/26 | ||
| High | 78.00 on 05/13/26 | 39.56 on 05/13/26 | 43.07 on 05/13/26 | ||
| 1-Month | |||||
| %Chg | -9.13% since 04/17/26 | +6.36% since 04/17/26 | +10.23% since 04/17/26 | ||
| Low | 64.98 on 05/19/26 | 32.83 on 04/27/26 | 33.23 on 05/01/26 | ||
| High | 78.80 on 05/11/26 | 39.56 on 05/13/26 | 44.65 on 05/08/26 | ||
| 3-Month | |||||
| %Chg | +75.47% since 02/19/26 | +14.77% since 02/19/26 | +32.20% since 02/19/26 | ||
| Low | 37.81 on 02/20/26 | 27.00 on 03/19/26 | 26.76 on 03/12/26 | ||
| High | 78.80 on 05/11/26 | 39.56 on 05/13/26 | 44.65 on 05/08/26 | ||
| 6-Month | |||||
| %Chg | +173.02% since 11/19/25 | +28.01% since 11/19/25 | +28.40% since 11/19/25 | ||
| Low | 23.01 on 11/21/25 | 27.00 on 03/19/26 | 26.76 on 03/12/26 | ||
| High | 78.80 on 05/11/26 | 39.56 on 05/13/26 | 44.65 on 05/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,085,818 | 6,198,680 | 6,043,756 | ||
| Shares Outstanding, K | 86,841 | 166,676 | 153,084 | ||
| Annual Sales | 0 | 1,475,900,000 | 616,290,000 | ||
| Annual Net Income | -155,200,000 | 241,660,000 | 447,180,000 | ||
| Last Quarter Sales | 0 | 392,910,000 | 204,920,000 | ||
| Last Quarter Net Income | -69,010,000 | -66,480,000 | 19,780,000 | ||
| 60-Month Beta | 3.12 | 0.31 | 1.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/05/26 | -0.40 on 05/05/26 | 0.17 on 05/06/26 | ||
| Earnings Date | 08/04/26 | 08/04/26 | 08/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 39.45 | 13.57 | ||